Replies to post #101 on Portola Phramaceuticals (PTLA)

[doingmybest]

I presume you are thinking Betrixiban PDUFA in June results in an approval in 2017. You must be suspect of the timing of the CRL resolution and resubmission. We should hear on Jan 10 but I am thinking the resubmission occurs by June and that it will be a Class 1 resubmission which will only take FDA 2 mos to review and decide, presumably approval. Jan 10 should be interesting.